Who is this course for?
Prescribing psychiatrists, healthcare and mental health professionals, and other eligible practitioners who may deliver psychedelic-assisted therapies as part of a multidisciplinary team.
The Certificate in Psychedelic-Assisted Therapies (CPAT)™ is a hybrid professional training program for healthcare and mental health professionals and other eligible practitioners. It covers the safe and effective delivery of psychedelic-assisted therapies in clinical settings, with a focus on psilocybin, MDMA and keta
Next cohort: Oct 1, 2026
113 hours
Start date: October 1, 2026
Delivered by Mind Medicine Australia, CPAT™ combines online learning with face-to-face residential intensives and provides more than 127 CPD-accredited hours of training. The program is designed for prescribing psychiatrists and other mental health professionals involved in delivering psychedelic-assisted therapies as part of multidisciplinary teams. The curriculum covers best-practice approaches to psychedelic-assisted therapy, with a focus on psilocybin, MDMA and ketamine-assisted therapy. Training is delivered by an international faculty of practitioners and researchers in the field. Graduates may gain access to professional experience at the Mind Medicine Australia Clinic and Centre of Excellence, as well as alumni professional development, supervision and peer support opportunities.
Prescribing psychiatrists, healthcare and mental health professionals, and other eligible practitioners who may deliver psychedelic-assisted therapies as part of a multidisciplinary team.
Eligibility is required, but specific prerequisite criteria are not provided in the source text.
Mind Medicine Australia is a national nonprofit that has played a defining role in Australia's regulated psychedelic-access environment. Its public work spans rescheduling advocacy, implementation support, clinician training, patient support funding, and ongoing efforts to broaden access pathways. Although it is broader than a pure patient group, it is too important to leave out of Blossom's access map. The organization now reports active involvement in regulatory follow-through, rollout improvements, patient support, and collaboration with End Wise on palliative-care expansion.
View all Mind Medicine Australia coursesPrescribing psychiatrists, healthcare and mental health professionals, and other eligible practitioners who may deliver psychedelic-assisted therapies as part of a multidisciplinary team.
Eligibility is required, but specific prerequisite criteria are not provided in the source text.
Format: Hybrid. Time commitment: 113 hours.
This listing does not have a public price yet. Check the provider website for current tuition, fees, or application-based pricing.
The listing includes a certificate signal. Accreditation note: CPD. Confirm credential eligibility directly with the provider before enrolling.
The listed next cohort date is 2026-10-01.
The current listing status is Active. Use the provider website for the latest enrollment status.
By CIIS
Shares course skills and categories
A professional certificate program in psychedelic-assisted therapies and research offered by CIIS. It covers clinical and research foundations including pharmacology, research design, therapist competencies, and cultural and historical context.
Dates not announced
By Psyched Soul
Shares course skills and categories
Psychedelic Therapy & Healing: From Theory to Practice is a comprehensive course designed for individuals interested in understanding the use of psychedelics for therapeutic and healing purposes. The course provides detailed information on the clinical pharmacology of psychedelics such as MDMA,
Self-paced access
Delivery: Online
By Atma Journey
Shares course skills and categories
An in-person workshop covering psychedelic history, research, legal and ethical frameworks, psychedelic medicines, and considerations for becoming a psychedelic therapist in Alberta. The workshop is designed for healthcare practitioners and students seeking foundational knowledge of psychedelic-assisted therapy.
Dates not announced